Reversing the Tumor Target: Establishment of a Tumor Trap

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéuticagl
dc.contributor.authorNajberg, Mathie
dc.contributor.authorHaji Mansor, Muhammad
dc.contributor.authorBoury, Frank
dc.contributor.authorÁlvarez Lorenzo, Carmen
dc.contributor.authorGarcion, Emmanuel
dc.date.accessioned2020-04-06T16:46:39Z
dc.date.available2020-04-06T16:46:39Z
dc.date.issued2019
dc.description.abstractDespite the tremendous progress made in the field of cancer therapy in recent years, certain solid tumors still cannot be successfully treated. Alongside classical treatments in the form of chemotherapy and/or radiotherapy, targeted treatments such as immunotherapy that cause fewer side effects emerge as new options in the clinics. However, these alternative treatments may not be useful for treating all types of cancers, especially for killing infiltrative and circulating tumor cells (CTCs). Recent advances pursue the trapping of these cancer cells within a confined area to facilitate their removal for therapeutic and diagnostic purposes. A good understanding of the mechanisms behind tumor cell migration may drive the design of traps that mimic natural tumor niches and guide the movement of the cancer cells. To bring this trapping idea into reality, strong efforts are being made to create structured materials that imitate myelinated fibers, blood vessels, or pre-metastatic niches and incorporate chemical cues such as chemoattractants or adhesive proteins. In this review, the different strategies used (or could be used) to trap tumor cells are described, and relevant examples of their performance are analyzed.gl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was supported by the “Institut National de la Santé et de la Recherche Médicale” (INSERM), the University of Angers (Angers, France), the MINECO (SAF2017-83118-R), the Agencia Estatal de Investigacion (AEI, Spain), and the Fondo Europeo de Desarollo Regional (FEDER). It is also related to the LabEx IRON “Innovative Radiopharmaceuticals in Oncology and Neurology” as part of the French government “Investissements d’Avenir” program, to the INCa (Institut National du Cancer) MARENGO consortium “MicroRNA agonist and antagonist Nanomedicines for GliOblastoma treatment: from molecular programmation to preclinical validation” through the PL-BIO 2014-2020 grant and to the MuMoFRaT project “Multi-scale Modeling & simulation of the response to hypo-Fractionated Radiotherapy or repeated molecular radiation Therapies” supported by “La Région Pays-de-la-Loire” and by the Cancéropôle Grand-Ouest (tumor targeting and radiotherapy network). MN was a Ph.D. student involved in the Erasmus Mundus Joint Doctorate program for Nanomedicine and pharmaceutical innovation (EMJD NanoFar) and received a fellowship from “La Région Pays-de-la-Loire.”gl
dc.identifier.citationNajberg, M., Haji Mansor, M., Boury, F., Alvarez-Lorenzo, C., Garcion, E. (2019). Reversing the Tumor Target: Establishment of a Tumor Trap. "Frontiers in Pharmacology", 10:887gl
dc.identifier.doi10.3389/fphar.2019.00887
dc.identifier.essn1663-9812
dc.identifier.urihttp://hdl.handle.net/10347/21195
dc.language.isoenggl
dc.publisherFrontiers Mediagl
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/SAF2017-83118-R/ES/ARQUITECTURAS POLIMERICAS 3D ACTIVAS PARA MEDICINA REGENERATIVA Y TERAPIA LOCALIZADA
dc.relation.publisherversionhttps://doi.org/10.3389/fphar.2019.00887gl
dc.rights© 2019 Najberg, Haji Mansor, Boury, Alvarez-Lorenzo and Garcion. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these termsgl
dc.rights.accessRightsopen accessgl
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectTumor cell migrationgl
dc.subjectTumor trapgl
dc.subjectBiomimetic trapgl
dc.subjectCancer therapygl
dc.subjectPremetastatic niche recruitmentgl
dc.titleReversing the Tumor Target: Establishment of a Tumor Trapgl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication44d6632e-65cd-485a-bb67-86df5567793a
relation.isAuthorOfPublication.latestForDiscovery44d6632e-65cd-485a-bb67-86df5567793a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019_frontiers_najberg_tumor_target.pdf
Size:
2.6 MB
Format:
Adobe Portable Document Format
Description: